T Gayowski

Author PubWeight™ 67.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000 2.91
2 Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 1995 1.59
3 High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med 1994 1.59
4 Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int 1996 1.45
5 The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998 1.42
6 Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995 1.31
7 Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis 1997 1.28
8 Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995 1.28
9 Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine (Baltimore) 1994 1.17
10 Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis. Clin Infect Dis 1999 1.15
11 Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 2000 1.11
12 Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000 1.10
13 Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit. Clin Microbiol Infect 2003 1.07
14 Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation 1990 1.04
15 Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C. Transplantation 1999 1.04
16 Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997 1.03
17 Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus. Clin Transplant 1997 1.01
18 Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. Transplantation 1994 1.01
19 Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation 1998 0.97
20 Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 1996 0.95
21 Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial. Transplantation 2000 0.94
22 Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infect Control Hosp Epidemiol 1998 0.94
23 Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000 0.94
24 Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci 1997 0.93
25 Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation 1998 0.92
26 Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996 0.92
27 Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis 1998 0.92
28 Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol 1998 0.92
29 Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen. Transpl Int 1998 0.91
30 Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001 0.89
31 Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 1997 0.89
32 Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. Eur J Clin Microbiol Infect Dis 1997 0.87
33 Toxoplasma gondii pneumonitis in a liver transplant recipient: implications for diagnosis. Liver Transpl Surg 1996 0.87
34 Intraoperative hypothermia is an independent risk factor for early cytomegalovirus infection in liver transplant recipients. Transplantation 1999 0.86
35 Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis. Clin Transplant 2000 0.86
36 Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001 0.86
37 Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation 1995 0.85
38 Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc 1995 0.85
39 Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000 0.84
40 Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation. Surgery 1996 0.84
41 Psychological characteristics of candidates for liver transplantation: differences according to history of substance abuse and UNOS listing. United Network for Organ Sharing. J Clin Psychol 1999 0.84
42 Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997 0.84
43 Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients. Liver Transpl 2001 0.83
44 Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center. J Infect Dis 1997 0.83
45 Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil. Transplantation 1998 0.83
46 Pulmonary infiltrates in liver transplant recipients in the intensive care unit. Transplantation 1999 0.83
47 Mycobacterium mucogenicum bacteremia in a patient with cirrhosis. J Clin Gastroenterol 1998 0.83
48 Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin Transplant 1997 0.82
49 Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997 0.82
50 Causes of leukocytosis in liver transplant recipients: relevance in clinical practice. Transplantation 1998 0.82
51 Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient. Liver Transpl Surg 1999 0.81
52 Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. Transplant Proc 1993 0.81
53 Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies. Transplantation 1996 0.80
54 Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy. Clin Transplant 1996 0.80
55 Psychological characteristics of candidates for liver transplantation. Clin Transplant 1998 0.79
56 Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc 1997 0.79
57 Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D. Liver Transpl 2000 0.78
58 Pulmonary nodules in liver transplant recipients. Medicine (Baltimore) 1998 0.78
59 Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients. Clin Transplant 1996 0.78
60 Cutaneous cryptococcosis mimicking bacterial cellulitis in a liver transplant recipient: case report and review in solid organ transplant recipients. Clin Transplant 1994 0.78
61 Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis. Transpl Int 1998 0.78
62 Seasonal pattern of early mortality and infectious complications in liver transplant recipients. Liver Transpl 2001 0.78
63 Acute adrenal insufficiency in critically ill liver transplant recipients. Implications for diagnosis. Transplantation 1995 0.78
64 Legionella infection in liver transplant recipients: implications for management. Transplantation 1993 0.77
65 Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation. Transplantation 1997 0.77
66 Persistent lack of human herpesvirus-6 specific T-helper cell response in liver transplant recipients. Transpl Infect Dis 2002 0.76
67 Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation 1997 0.76
68 Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension. Liver Transpl Surg 1997 0.76
69 Multicultural issues in organ transplantation: the influence of patients' cultural perspectives on compliance with treatment. Clin Transplant 1997 0.76
70 Cytomegalovirus and death in liver transplantation. Ann Intern Med 1997 0.75
71 Re: Nashville experience with liver transplantation in U.S. Veterans. J Surg Res 1997 0.75
72 Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? Ann Neurol 1997 0.75
73 Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B. Clin Infect Dis 1993 0.75
74 Transjugular intrahepatic portosystemic shunt (TIPS) complicated by complete heart block. Anaesth Intensive Care 1997 0.75
75 Intensive care unit management in liver transplant recipients: beneficial effect on survival and preservation of quality of life. Clin Transplant 1997 0.75
76 T-helper cell responses in liver transplant recipients: correlation with cytomegalovirus and other major infections. Transpl Infect Dis 2004 0.75
77 Fever in liver transplant recipients in the intensive care unit. Clin Transplant 1999 0.75
78 Herpes zoster-associated idiopathic thrombocytopenic purpura in a liver transplant recipient: a case report and overview. Transpl Int 1995 0.75
79 Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation. Transplantation 1995 0.75
80 Rapidly fatal bacteremia due to Staphylococcus aureus producing both enterotoxins A and B in a liver transplant recipient. Clin Infect Dis 1997 0.75
81 Improved detection of spontaneous bacterial peritonitis with Bactec as compared with conventional culture methods. A prospective study. Diagn Microbiol Infect Dis 1994 0.75
82 Cirrhotic fever in the 1990s: a prospective study with clinical implications. Clin Infect Dis 1997 0.75